title: Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia.
abstract: OBJECTIVE
  To estimate the proportion of community-dwelling older adults with dementia being prescribed a psychotropic and to identify patient and caregiver factors associated with antipsychotic use.
  
  
  METHODS
  Retrospective cohort study of the Aging, Demographics, and Memory Study (ADAMS) from 2002 to 2004 designed to assess dementia severity and service use of community-dwelling older adults. The frequency of psychotropic medication (antipsychotics, antidepressants, anticonvulsants, and benzodiazepines) use was tabulated and weighted to the U.S. population according to dementia diagnosis. Logistic regression analysis identified factors associated with antipsychotic use.
  
  
  RESULTS
  The 307 ADAMS participants had the following dementia diagnoses: Alzheimer's disease (69.3%), vascular dementia (17.7%), and other dementia (12.4%). The proportion of participants prescribed a psychotropic medication broken down according to therapeutic class was 19.1% antipsychotics, 29.1% antidepressants, 9.8% benzodiazepines, and 8.8% anticonvulsants. Older adults with dementia were significantly more likely to receive an antipsychotic if they had moderate (odds ratio (OR) = 7.4, P = .002) or severe (OR = 5.80, P = .002) dementia than if they had mild dementia or were diagnosed with Alzheimer's disease (OR = 6.7, P = .04) compared to vascular dementia. Older adults with dementia who lived with a caregiver were significantly less likely to taking an antipsychotic (OR = 0.19, P = .001) than those who lived alone. Also, persons with dementia were significantly less likely to be prescribed an antipsychotic if their caregiver was clinically depressed (OR = 0.03, P = .005) than if their caregiver was not depressed.
  
  
  CONCLUSIONS
  Psychotropic medication use is common in community-dwelling older adults with dementia. Caregivers appear to have a substantial effect on whether an antipsychotic is prescribed, which adds additional complexity to conversations discussing the risk:benefit ratio of this medication class.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Northwestern University, Chicago, IL, USA. y-rhee@northwestern.edu
authors.forename: YongJoo
authors.initials: Y
authors.lastname: Rhee
authors.forename: John G
authors.initials: JG
authors.lastname: Csernansky
authors.forename: Linda L
authors.initials: LL
authors.lastname: Emanuel
authors.forename: Chang-Gok
authors.initials: CG
authors.lastname: Chang
authors.forename: Joseph W
authors.initials: JW
authors.lastname: Shega
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D017028:Caregivers / Q000523:psychology; D003704:Dementia / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012111:Residence Characteristics; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D011619:Psychotropic Drugs
references.citation: Maturitas. 2010 Jun;66(2):191-200
references.pmid: 20307942
references.citation: Arch Intern Med. 2010 Jan 11;170(1):96-103
references.pmid: 20065205
references.citation: Am J Geriatr Psychiatry. 2005 Jun;13(6):460-8
references.pmid: 15956265
references.citation: Neuropsychopharmacology. 2008 Apr;33(5):957-70
references.pmid: 17637610
references.citation: Arch Neurol. 2003 Aug;60(8):1119-22
references.pmid: 12925369
references.citation: J Am Geriatr Soc. 2006 May;54(5):796-803
references.pmid: 16696746
references.citation: Am J Geriatr Psychiatry. 2008 Jul;16(7):594-602
references.pmid: 18591579
references.citation: JAMA. 1997 Mar 12;277(10):806-12
references.pmid: 9052710
references.citation: J Neuropsychiatry Clin Neurosci. 1997 Fall;9(4):556-61
references.pmid: 9447496
references.citation: Ann Intern Med. 2008 Mar 4;148(5):379-97
references.pmid: 18316756
references.citation: Int J Geriatr Psychiatry. 2000 Feb;15(2):181-9
references.pmid: 10679850
references.citation: Health Serv Res. 2008 Apr;43(2):693-713
references.pmid: 18370974
references.citation: Am J Geriatr Psychiatry. 2010 Oct;18(10):917-27
references.pmid: 20808108
references.citation: N Engl J Med. 2006 Oct 12;355(15):1525-38
references.pmid: 17035647
references.citation: JAMA. 2005 Oct 19;294(15):1934-43
references.pmid: 16234500
references.citation: Gerontologist. 2007 Aug;47(4):423-37
references.pmid: 17766664
references.citation: Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):195-201
references.pmid: 16327346
references.citation: JAMA. 2002 Apr 24;287(16):2090-7
references.pmid: 11966383
references.citation: JAMA. 2002 Sep 25;288(12):1475-83
references.pmid: 12243634
references.citation: Age Ageing. 2010 Sep;39(5):637-42
references.pmid: 20625185
references.citation: J Alzheimers Dis. 2009;17(1):105-14
references.pmid: 19494435
references.citation: Am J Geriatr Psychiatry. 2010 Dec;18(12):1078-92
references.pmid: 20808119
references.citation: Neurology. 1994 Dec;44(12):2308-14
references.pmid: 7991117
references.citation: Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210
references.pmid: 16505124
references.citation: Alzheimers Dement. 2010 Mar;6(2):158-94
references.pmid: 20298981
references.citation: Alzheimer Dis Assoc Disord. 2004 Apr-Jun;18(2):99-109
references.pmid: 15249854
references.citation: J Am Geriatr Soc. 2011 Mar;59(3):488-94
references.pmid: 21391939
references.citation: Int Psychogeriatr. 2010 Dec;22(8):1310-7
references.pmid: 20637136
references.citation: Neurology. 1993 Nov;43(11):2412-4
references.pmid: 8232972
references.citation: Neuroepidemiology. 2005;25(4):181-91
references.pmid: 16103729
references.citation: J Gerontol B Psychol Sci Soc Sci. 2000 Jan;55(1):S2-13
references.pmid: 10728125